{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:01:06Z","timestamp":1790751666790,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01 HS018366-01A1"],"award-info":[{"award-number":["R01 HS018366-01A1"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA154292"],"award-info":[{"award-number":["P01CA154292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA163303"],"award-info":[{"award-number":["U54CA163303"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA149365"],"award-info":[{"award-number":["R01CA149365"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R50CA211115"],"award-info":[{"award-number":["R50CA211115"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["PCS-1504-30370"],"award-info":[{"award-number":["PCS-1504-30370"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10549-023-07051-6","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T15:07:43Z","timestamp":1694444863000},"page":"505-514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Digital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinoma"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-3040","authenticated-orcid":false,"given":"Tracy","family":"Onega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Miglioretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph I.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise M.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Kerlikowske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna N. A.","family":"Tosteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J. Aiello","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta M.","family":"di Florio-Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"7051_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10549-022-06572-w","volume":"193","author":"JA Mouabbi","year":"2022","unstructured":"Mouabbi JA, Hassan A, Lim B et al (2022) Invasive lobular carcinoma: an understudied emergent subtype of breast cancer. Breast Cancer Res Treat 193:253\u2013264","journal-title":"Breast Cancer Res Treat"},{"key":"7051_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13058-015-0605-0","volume":"17","author":"K Johnson","year":"2015","unstructured":"Johnson K, Sarma D, Hwang ES (2015) Lobular breast cancer series: imaging. Breast Cancer Res 17:94","journal-title":"Breast Cancer Res"},{"issue":"1","key":"7051_CR3","first-page":"1","volume":"5","author":"AJ Porter","year":"2013","unstructured":"Porter AJ, Evans EB, Foxcroft LM et al (2013) Mammographic and ultrasound features of invasive lobular carcinoma of the breast. J Med Imag Rad Oncol 5(1):1\u201310","journal-title":"J Med Imag Rad Oncol"},{"key":"7051_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13058-020-01384-6","volume":"23","author":"AE McCart Reed","year":"2021","unstructured":"McCart Reed AE, Kalinowski L, Simpson PT et al (2021) Invasive lobular carcinoma of the breast: the increasing importance of this special subtype. Breast Cancer Res Treat 23:6. https:\/\/doi.org\/10.1186\/s13058-020-01384-6","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"7051_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/jimaging7090185","volume":"7","author":"G Romanucci","year":"2021","unstructured":"Romanucci G, Zantedeschi L, Ventriglia A et al (2021) Lobular breast cancer conspicuity on digital breast tomosynthesis compared to synthesized 2D mammography: a multireader study. J Imag 7(9):185. https:\/\/doi.org\/10.3390\/jimaging7090185","journal-title":"J Imag"},{"issue":"6","key":"7051_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jamaoncol.2015.5536","volume":"2","author":"ES McDonald","year":"2016","unstructured":"McDonald ES, Oustimov A, Weinstein SP et al (2016) Effectiveness of digital breast tomosynthesis compared with digital mammography: outcomes analysis from 3 years of breast cancer screening. JAMA Oncol 2(6):737\u2013743. https:\/\/doi.org\/10.1001\/jamaoncol.2015.5536","journal-title":"JAMA Oncol"},{"issue":"6","key":"7051_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jnci\/djaa205","volume":"113","author":"M Alabousi","year":"2021","unstructured":"Alabousi M, Wadera A, Kashif Al-Ghita M et al (2021) Performance of digital breast tomosynthesis, synthetic f\u00a2mammography, and digital mammography in breast cancer screening: a systematic review and meta-analysis. J Nat Cancer Institute 113(6):680\u2013690","journal-title":"J Nat Cancer Institute"},{"issue":"7","key":"7051_CR8","doi-asserted-by":"publisher","first-page":"e2011792","DOI":"10.1001\/jamanetworkopen.2020.11792","volume":"3","author":"KP Lowry","year":"2021","unstructured":"Lowry KP, Coley RY, Miglioretti DL et al (2021) Screening performance of digital breast tomosynthesis vs digital mammography in community practice by patient age, screening round, and breast density. JAMA Netw Open 3(7):e2011792\u2013e2011792","journal-title":"JAMA Netw Open"},{"issue":"22","key":"7051_CR9","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1001\/jama.2022.7672","volume":"327","author":"K Kerlikowske","year":"2022","unstructured":"Kerlikowske K, Su Y, Sprague BL et al (2022) Association of screening with digital breast tomosynthesis vs digital mammography with risk of interval invasive and advanced breast cancer. JAMA 327(22):2220\u20132230. https:\/\/doi.org\/10.1001\/jama.2022.7672","journal-title":"JAMA"},{"key":"7051_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1186\/2193-1801-2-621","volume":"2","author":"GLG Menezes","year":"2013","unstructured":"Menezes GLG, van den Bosch MAAJ, Postma EL et al (2013) Invasive ductolobular carcinoma of the breast: spectrum of mammographic, ultrasound and magnetic resonance imaging findings correlated with proportion of the lobular component. Springerplus 2:621","journal-title":"Springerplus"},{"key":"7051_CR11","doi-asserted-by":"publisher","first-page":"20170128","DOI":"10.1259\/bjr.20170128","volume":"90","author":"F Chammings","year":"2017","unstructured":"Chammings F, Kao E, Ladis A et al (2017) Imagine features and conspicuity of invasive lobular carcinomas on digital breast tomosynthesis. Br J Radiol 90:20170128","journal-title":"Br J Radiol"},{"key":"7051_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000450868","volume":"11","author":"A Grubstein","year":"2016","unstructured":"Grubstein A, Rapson Y, Morgenstern S et al (2016) Invasive lobular carcinoma of the breast: appearance on digital breast tomosynthesis. Breast Care 11:359\u2013362","journal-title":"Breast Care"},{"issue":"9","key":"7051_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.crad.2016.04.004","volume":"71","author":"G Mariscotti","year":"2016","unstructured":"Mariscotti G, Durando M, Houssami N et al (2016) Digital breast tomosynthesis as an adjunct to digital mammography for detecting and characterising invasive lobular cancers: a multi-reader study. Clin Radiol 71(9):889\u2013895","journal-title":"Clin Radiol"},{"key":"7051_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10549-017-4298-1","volume":"164","author":"SJ Yun","year":"2017","unstructured":"Yun SJ, Ryu CW, Rhee SJ et al (2017) Benefit of adding digital breast tomosynthesis to digital mammography for breast cancer screening focused on cancer characteristics: a meta-analysis. Breast Cancer Res Treat 164:557\u2013569","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7051_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2214\/AJR.18.20255","volume":"212","author":"MH Fuji","year":"2019","unstructured":"Fuji MH, Herschorn SD, Sowden M et al (2019) Detection rates for benign and malignant diagnoses on breast cancer screening with digital breast tomosynthesis in a statewide mammography registry study. AJR Am J Roentgenol 212(3):706","journal-title":"AJR Am J Roentgenol"},{"key":"7051_CR16","unstructured":"Breast Cancer Surveillance Consortium. About the BCSC :: BCSC (bcsc-research.org). Last Accessed: 7\/31\/2022."},{"key":"7051_CR17","unstructured":"Breast Cancer Surveillance Consortium. Standard Definitions :: BCSC (bcsc-research.org). Last Accessed: 7\/31\/2022."},{"key":"7051_CR18","doi-asserted-by":"crossref","unstructured":"Arpino G, Bardou VJ, Clark GM, et al. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6(3):R149\u201356. Da Ros L, Moretti A, Querzoli P, et al. HER2-positive lobular versus ductal carcinoma of the breast: pattern of first recurrence and molecular insights. Clin Breast Cancer. 2018;18(5):e1133\u20139.","DOI":"10.1016\/j.clbc.2018.04.006"},{"issue":"22","key":"7051_CR19","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1002\/cncr.33104","volume":"126","author":"M Christgen","year":"2020","unstructured":"Christgen M, Gluz O, Harbeck N et al (2020) Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer. Cancer 126(22):4847\u20134858","journal-title":"Cancer"},{"issue":"1","key":"7051_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10549-019-05234-8","volume":"176","author":"D Flores-Diaz","year":"2019","unstructured":"Flores-Diaz D, Arce C, Flores-Luna L et al (2019) Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients. Breast Cancer Res Treat 176(1):243\u2013249","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7051_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10549-019-05277-x","volume":"176","author":"K Altundag","year":"2019","unstructured":"Altundag K (2019) HER2+ and triple-negative phenotypes in invasive lobular carcinoma might have different specific biological features. Breast Cancer Res Treat 176(3):719","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"7051_CR22","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1810527","volume":"379","author":"NC Turner","year":"2018","unstructured":"Turner NC, Slamon DJ, Ro J et al (2018) Overall survival with palbociclib and fulvestrant in advanced breast cancer. N Engl J Med 379(20):1926\u20131936","journal-title":"N Engl J Med"},{"key":"7051_CR23","unstructured":"Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) United states: National library of Medicine; 2016 [Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT0276454. Accessed Oct 2020."},{"key":"7051_CR24","unstructured":"Assessing Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer (GELATO) Netherlands2017 Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03147040. Accessed Oct 2020."},{"key":"7051_CR25","unstructured":"ROS1 Targeting With Crizotinib in Advanced E-cadherin Negative, ER Positive Lobular Breast Cancer or Diffuse Gastric Cancer Study (ROLo) United Kingdom2019 [Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT0362064. Accessed Oct 2020."},{"key":"7051_CR26","unstructured":"Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) [available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04551495]. Accessed Oct 2020."},{"issue":"8","key":"7051_CR27","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1634\/theoncologist.2018-0182","volume":"24","author":"J Perez-Garcia","year":"2019","unstructured":"Perez-Garcia J, Cortes J, Metzger-Filho O (2019) Efficacy of single-agent chemotherapy for patients with advanced invasive lobular carcinoma: a pooled analysis from three clinical trials. Oncologist 24(8):1041\u20131047","journal-title":"Oncologist"},{"issue":"2","key":"7051_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1200\/JCO.18.00440","volume":"37","author":"T Ruhstaller","year":"2019","unstructured":"Ruhstaller T, Giobbie-Hurder A, Colleoni M et al (2019) Adjuvant letrozole and tamoxifen alone or sequentially for postmenopausal women with hormone receptor-positive breast cancer: long-term follow-up of the BIG 1\u201398 trial. J Clin Oncol 37(2):105\u2013114","journal-title":"J Clin Oncol"},{"issue":"7","key":"7051_CR29","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1634\/theoncologist.2018-0363","volume":"24","author":"O Metzger-Filho","year":"2019","unstructured":"Metzger-Filho O, Ferreira AR, Jeselsohn R et al (2019) Mixed invasive ductal and lobular carcinoma of the breast: prognosis and the importance of histologic grade. Oncologist 24(7):e441\u2013e449. https:\/\/doi.org\/10.1634\/theoncologist.2018-0363","journal-title":"Oncologist"},{"issue":"6","key":"7051_CR30","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.2214\/AJR.20.23480","volume":"216","author":"MP Hogan","year":"2021","unstructured":"Hogan MP, Amir T, Sevilimedu V et al (2021) AJR Am J Roentgenol 216(6):1486\u20131491. https:\/\/doi.org\/10.2214\/AJR.20.23480","journal-title":"AJR Am J Roentgenol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07051-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T07:11:53Z","timestamp":1696921913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07051-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["7051"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07051-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.I. Lee receives personal fees from the American College of Radiology for journal editorial board work and textbook royalties from UpToDate, Inc., Oxford University Press, and McGraw Hill, Inc. There are no other conflicts of interest to disclosure for any of the other authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}